Contact FreedomWorks

111 K Street NE
Suite 600
Washington, DC 20002

  • Toll Free 1.888.564.6273
  • Local 202.783.3870
LISTEN NOWFood Fights, Lyin' Liz, and Omar's Outrageous Plan | Pardon The Disruption Ep. #07Listen Here
Record Number of People Dependent on Government Programs
null
http://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=35IWEBMb
Blog

Record Number of People Dependent on Government Programs

USA Today reports that a record number of Americans—one in six—are now dependent on government anti-poverty programs. Since the recession began in December 2007, the enrollment and cost of government programs have grown at an alarming rate.

09/01/2010
The Sources of Insurance (Issue Analysis Number 126)
null
http://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=35IWEBMb
Press Release

The Sources of Insurance (Issue Analysis Number 126)

Download a .pdf version of the full study complete with footnotes and graphs by clicking here! Executive Summary

07/08/2009
Unsettling Science in the Health Care Debate
null
http://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=35IWEBMb
Blog

Unsettling Science in the Health Care Debate

Settled science rarely is. Except to those with a vested policy interest in the debate. True to form, a recent diatribe by Michael F. Jacobson of the Center for Science in the Public Interest acknowledges none of the widely available data that conflict with his passionate crusade against table salt. However, to a debate that has endured for decades, Jacobson does bring a modern twist:

06/11/2009
Beware of Strange Bedfellows in Washington
null
http://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=35IWEBMb
Blog

Beware of Strange Bedfellows in Washington

The consumer group Families USA and Pharmaceutical Research and Manufacturers of America (PhRMA) are teaming up in Washington to lobby to increase coverage for Medicaid.  Why would the medical companies support more government intervention in their industry?  Maybe because they did a cost-benefit analysis and concluded that they would make more money with more interventions.  According to Politico, "The upside is that it would help drug companies tap a new market by providing coverage to those who are too poor to buy drugs."  These groups worked together on S-CHIP as well, likely for the same reason.

04/21/2009

Pages